BEVERLY HILLS, Calif., Sept. 18, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to announce that Company advisor and advocate Dr. Jennifer R. Berman, MD has been selected to appear on the nationally syndicated The Ricki Lake Show as women's sexual health expert. The special episode will cover all issues related to a woman's sexual health and well-being. Studio taping of the show is scheduled for Wednesday, September 19, 2012.
"Dr. Berman's knowledge and understanding of women's sexual health issues has made her a reliable source of information for women. Her ability to candidly discuss and explain these issues in a compassionate and compelling way has endeared her to television audiences for many years. I have no doubt that she will win over the Ricki Lake Show viewers as well," stated Michael Borkowski, CEO of Eaton Scientific. "This is the first of several planned television appearances in the works for Dr. Berman over the next few weeks that should give her the opportunity to discuss menopause, hot flashes, and Tropine 3, Eaton's novel non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal experiencing hot flashes."
The Ricki Lake Show is an American first-run syndicated talk show hosted by acclaimed television personality and actress Ricki Lake. The new series debuted in United States and Canada on September 10, 2012. The series also marked her return to talk television after leaving the genre in 2004 after 11 seasons (Ricki Lake - September 13, 1993 to May 25, 2004). The new talk show will present topical conversation reflecting Ricki's own personal journey and recent life experiences. As her fans have grown up with Ricki, a combination of relevant themes personal to the host and her audience including family, marriage, parenting, divorce, weight loss and overall well-being will be explored for the program. The show is co-produced by both 20th Television and Monet Lane Productions.
About Pristine Solutions, Inc.
Pristine Solutions, Inc., through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women. The company is preparing for Phase 1 & 2 Clinical Trials with the goal of FDA approval of Tropine 3.
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Pristine Solutions' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Pristine Solutions' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Pristine Solutions herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Pristine Solutions disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
SOURCE Eaton Scientific Systems, Ltd.